en

PRODUCT DETAIL

Pylera 140 mg/125 mg/125 mg tvrdé kapsuly

Code 0405B
MA number 15/0199/14-S
Product Form: cps dur 120x140 mg/125 mg/125 mg (fľ.HDPE)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM)
ATC:
A ALIMENTARY TRACT AND METABOLISM
A02 DRUGS FOR ACID RELATED DISORDERS
A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX
A02BD Combinations for eradication of Helicobacter pylor
A02BD08 Bismuth subcitrate, tetracycline and metronidazole
Shelf life: 36
Container: bottle HDPE
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10b fixed combination application
MA issued: 23.06.2014
Pediatric posology: Yes
Pediatric contraindication: Yes
PIL: PIL_Pylera140 mg_125 mg_125 mg cps dur_02.2023.pdf  
SPC: SPC_Pylera140 mg_125 mg_125 mg cps dur_02.2023.pdf  
Safety feature Yes
Data update: 20.09.2019
eu-flag.png sk-flag.png